Zacks Research Issues Pessimistic Estimate for MTD Earnings

Mettler-Toledo International Inc. (NYSE:MTD) – Investment analysts at Zacks Research lowered their Q1 2025 EPS estimates for Mettler-Toledo International in a research note issued on Monday, January 6th. Zacks Research analyst R. Department now forecasts that the medical instruments supplier will post earnings per share of $8.42 for the quarter, down from their prior forecast of $8.78. The consensus estimate for Mettler-Toledo International’s current full-year earnings is $40.42 per share. Zacks Research also issued estimates for Mettler-Toledo International’s Q2 2025 earnings at $10.25 EPS, FY2025 earnings at $41.94 EPS, Q1 2026 earnings at $9.97 EPS, Q2 2026 earnings at $11.03 EPS and FY2026 earnings at $48.62 EPS.

A number of other equities research analysts have also recently commented on the stock. Evercore ISI upgraded shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and raised their price target for the stock from $1,375.00 to $1,450.00 in a report on Thursday, January 2nd. Robert W. Baird cut their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Wells Fargo & Company decreased their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Wolfe Research assumed coverage on Mettler-Toledo International in a research report on Friday, December 13th. They issued a “peer perform” rating on the stock. Finally, Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and boosted their price target for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $1,351.25.

Mettler-Toledo International Stock Performance

Shares of MTD opened at $1,254.93 on Wednesday. The firm has a market cap of $26.48 billion, a PE ratio of 33.83, a price-to-earnings-growth ratio of 4.21 and a beta of 1.12. Mettler-Toledo International has a 52-week low of $1,122.21 and a 52-week high of $1,546.93. The business’s 50 day moving average price is $1,255.29 and its two-hundred day moving average price is $1,351.53.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The firm had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Blue Trust Inc. boosted its position in shares of Mettler-Toledo International by 242.9% in the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 17 shares during the period. Ashton Thomas Securities LLC purchased a new position in shares of Mettler-Toledo International in the third quarter valued at about $37,000. Itau Unibanco Holding S.A. bought a new stake in Mettler-Toledo International during the 2nd quarter valued at approximately $42,000. Raleigh Capital Management Inc. grew its holdings in Mettler-Toledo International by 272.7% during the 3rd quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier’s stock valued at $61,000 after buying an additional 30 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. grew its stake in Mettler-Toledo International by 60.0% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 48 shares of the medical instruments supplier’s stock valued at $72,000 after acquiring an additional 18 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the sale, the director now owns 240 shares in the company, valued at approximately $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Gerry Keller sold 140 shares of the stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the transaction, the insider now directly owns 6 shares in the company, valued at $7,524.54. The trade was a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.